COMMUNIQUÉS West-GlobeNewswire

HTG Molecular to Present Corporate Overview at the 8th Annual SVB Leerink Global Healthcare Conference
20/02/2019
TUCSON, Ariz., Feb. 20, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that TJ Johnson, Chief [...]
Principia Biopharma to Present at 8th Annual SVB Leerink Global Healthcare Conference
20/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with [...]
CymaBay Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference
20/02/2019
NEWARK, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]
Allogene Therapeutics Enters Lease to Build Manufacturing Facility to Develop and Commercialize Allogeneic CAR T (AlloCAR T™) Therapies
20/02/2019
State-of-the-Art Manufacturing Facility to be Located in the San Francisco East Bay Area Allogene Committed to Advanced Cell Manufacturing for Long-Term Clinical and Commercial AlloCAR T™ Production SOUTH SAN FRANCISCO [...]
BrainsWay Expands its Deep TMS Commercial Footprint into Asia Pacific
20/02/2019
Enters into an Agreement to Distribute its Deep Transcranial Magnetic Stimulation System in South Korea JERUSALEM, Feb. 20, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (TASE: BRIN) , a global leader in the advanced non- [...]
Fulgent Genetics to Announce Fourth Quarter and Full Year 2018 Financial Results on Thursday February 28, 2019
20/02/2019
TEMPLE CITY, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its fourth quarter and full year 2018 financial [...]
Progressive Care Inc. Announces Best January in Company History
20/02/2019
MIAMI, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and number of [...]
RedHill Biopharma Strengthens Management Team with Appointment of Rick D. Scruggs as Chief Operating Officer, U.S. Operations
20/02/2019
TEL-AVIV, Israel and RALEIGH, N.C., Feb. 20, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
BioSig Announces Successful First-In-Human Use of PURE EP System
20/02/2019
Early Results Suggest Improved Cardiac Signal Detection and Fidelity Santa Monica, CA, Feb. 20, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary [...]
AzurRx BioPharma Announces First Patients Dosed in Phase II OPTION Clinical Trial
20/02/2019
Initial top line data of MS1819-SD in Cystic Fibrosis Patients expected in mid-2019. First patients dosed in open-label, cross-over Phase II OPTION study with MS1819-SD for exocrine pancreatic insufficiency in cystic [...]
FIT Biotech Oy: Liquidity crisis, request for a tranche and changes to financial calendar and date of the Annual General Meeting
20/02/2019
FIT Biotech Oy Company release 20.02.2019 at 14:30 EET Liquidity crisis, request for a tranche and changes to financial calendar and date of the Annual General Meeting Despite the financing agreement in force, Alpha [...]
Moleculin Announces Outlicensing Deal To Accelerate Preclinical and Clinical Development
20/02/2019
HOUSTON, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]
Xeris Pharmaceuticals to Participate at SVB Leerink Global Healthcare Conference
20/02/2019
CHICAGO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable [...]
Harpoon Therapeutics to Present at SVB Leerink Global Healthcare Conference
20/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, announced today that Gerald [...]
Kura Oncology to Present at SVB Leerink Global Healthcare Conference
20/02/2019
SAN DIEGO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that Troy [...]
Blueberries Medical Acquires an Additional 37 Acres of Prime Agricultural Land to Significantly Increase Cannabis Production Capacity
20/02/2019
TORONTO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (the “ Company ” or " Blueberries ") a leading Colombia-based licenced producer of medicinal cannabis and cannabis-derived products is [...]
Marinus Pharmaceuticals to Present at the Leerink Healthcare Conference
20/02/2019
RADNOR, Pa., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and [...]
ARCA Biopharma Announces FDA Agreement for a Single Phase 3 Clinical Trial to Support Approval for the First Genetically-Targeted Cardiovascular Drug
20/02/2019
FDA Special Protocol Assessment agreement granted for PRECISION-AF clinical trial evaluating Gencaro as a potential treatment for atrial fibrillation in a heart failure population that has no FDA approved drug therapies [...]
Pluristem Enters into Collaboration with NASA to Study PLX Therapeutic Benefits in Space Missions
20/02/2019
Awarded NASA’s 2019 Ames Research Innovation Award HAIFA, Israel, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI) , a leading regenerative medicine company developing novel [...]

Pages